A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 7 filings in this group are Form 4s for Evogene Ltd.
The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.
Across the 7 insider filings shown, the breakdown is 4 compensation award and 3 open-market purchase. 3 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.
Form 4
Compensation award
Tax / Compensation Filing
2026-09-30
EVGN insider Form 4 filed for equity award, exercise, or tax withholding
RECANATI LEON (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Transactions reported on this filing
| Code |
Nature |
Shares |
Price |
Value |
A |
Compensation award
derivative · Stock Option (right to buy)
|
2,500 |
— |
— |
Filing: Form 4 (Insider Transaction)
Insider: RECANATI LEON (Director)
Form 4
Compensation award
Tax / Compensation Filing
2026-09-30
EVGN insider Form 4 filed for equity award, exercise, or tax withholding
Nimrodi Nir (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Transactions reported on this filing
| Code |
Nature |
Shares |
Price |
Value |
A |
Compensation award
derivative · Stock Option (right to buy)
|
10,000 |
— |
— |
Filing: Form 4 (Insider Transaction)
Insider: Nimrodi Nir (Director)
Form 4
Compensation award
Tax / Compensation Filing
2026-09-30
EVGN insider Form 4 filed for equity award, exercise, or tax withholding
Percy Adrian John (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Transactions reported on this filing
| Code |
Nature |
Shares |
Price |
Value |
A |
Compensation award
derivative · Stock Option (right to buy)
|
2,500 |
— |
— |
Filing: Form 4 (Insider Transaction)
Insider: Percy Adrian John (Director)
Form 4
Compensation award
Tax / Compensation Filing
2026-09-30
EVGN insider Form 4 filed for equity award, exercise, or tax withholding
Falk Dan Michael (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Transactions reported on this filing
| Code |
Nature |
Shares |
Price |
Value |
A |
Compensation award
derivative · Stock Option (right to buy)
|
2,500 |
— |
— |
Filing: Form 4 (Insider Transaction)
Insider: Falk Dan Michael (Director)
Form 4
Open-market purchase
Insider Buying
2026-08-26
EVGN insider Tarcic Gabi (Chief Development Officer) bought 1,129 shares (~$677.40)
Tarcic Gabi, listed as Chief Development Officer at Evogene Ltd., reported an open-market purchase of 1,129 EVGN shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.
The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.
Transactions reported on this filing
| Code |
Nature |
Shares |
Price |
Value |
P |
Open-market purchase
|
1,129 |
$0.60 |
$677.40 |
Filing: Form 4 (Insider Transaction)
Insider: Tarcic Gabi (Chief Development Officer)
Shares: 1,129
Est. Value: $677.40
Form 4
Open-market purchase
Insider Buying
2026-08-13
EVGN insider RECANATI LEON (Director) bought 460,000 shares (~$292.1K)
RECANATI LEON, listed as Director at Evogene Ltd., reported an open-market purchase of 460,000 EVGN shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.
The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.
Transactions reported on this filing
| Code |
Nature |
Shares |
Price |
Value |
P |
Open-market purchase
|
460,000 |
$0.64 |
$292.1K |
Filing: Form 4 (Insider Transaction)
Insider: RECANATI LEON (Director)
Shares: 460,000
Est. Value: $292.1K
Form 4
Open-market purchase
Insider Buying
2026-08-05
EVGN insider RECANATI LEON (Director) bought 800,000 shares (~$400.0K)
RECANATI LEON, listed as Director at Evogene Ltd., reported an open-market purchase of 800,000 EVGN shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.
The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.
Transactions reported on this filing
| Code |
Nature |
Shares |
Price |
Value |
P |
Open-market purchase
|
800,000 |
$0.50 |
$400.0K |
Filing: Form 4 (Insider Transaction)
Insider: RECANATI LEON (Director)
Shares: 800,000
Est. Value: $400.0K